MacroGenics, Inc. (MGNX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

MacroGenics, Inc. (MGNX) closed at USD 3.31 on 2026-10-14, a change of +78.9 % over the past year, with a market capitalization of USD 214.67M.

MacroGenics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

MacroGenics, Inc. key figures

Previous close

USD 3.31 (2026-10-14)

1-year change

+78.9 %

Market cap

USD 214.67M

Enterprise value

USD 76.46M

P/E ratio (trailing)

-2.01

P/E ratio (forward)

-2.30

EPS (trailing)

-1.68

EPS (forward)

-1.47

PEG ratio

n/a

Price to book

5.00

Revenue growth

378 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

12.63

Employees

293

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About MacroGenics, Inc.

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for MacroGenics, Inc. and compare it with other stocks.